EP1423119A4 - Heterobicyclen fkbp-liganden - Google Patents

Heterobicyclen fkbp-liganden

Info

Publication number
EP1423119A4
EP1423119A4 EP02731761A EP02731761A EP1423119A4 EP 1423119 A4 EP1423119 A4 EP 1423119A4 EP 02731761 A EP02731761 A EP 02731761A EP 02731761 A EP02731761 A EP 02731761A EP 1423119 A4 EP1423119 A4 EP 1423119A4
Authority
EP
European Patent Office
Prior art keywords
heterobicycles
fkbp
ligands
heterobicycles fkbp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02731761A
Other languages
English (en)
French (fr)
Other versions
EP1423119A1 (de
Inventor
Chuangxing Guo
Corinne E Augelli-Szafran
Nancy Sue Barta
Steven Lee Bender
Christopher Franklin Bigge
Bradley William Caprathe
Arindam Chatterjee
Judith Deal
Liming Dong
Lorraine Kathleen Fay
Xinjun Hou
Raymond Andrew Hudack Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agouron Pharmaceuticals LLC
Original Assignee
Agouron Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals LLC filed Critical Agouron Pharmaceuticals LLC
Publication of EP1423119A1 publication Critical patent/EP1423119A1/de
Publication of EP1423119A4 publication Critical patent/EP1423119A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EP02731761A 2001-05-10 2002-05-10 Heterobicyclen fkbp-liganden Withdrawn EP1423119A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28982801P 2001-05-10 2001-05-10
US289828P 2001-05-10
PCT/US2002/014966 WO2002089806A1 (en) 2001-05-10 2002-05-10 Heterobicycles fkbp-ligands

Publications (2)

Publication Number Publication Date
EP1423119A1 EP1423119A1 (de) 2004-06-02
EP1423119A4 true EP1423119A4 (de) 2005-04-13

Family

ID=23113278

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02731761A Withdrawn EP1423119A4 (de) 2001-05-10 2002-05-10 Heterobicyclen fkbp-liganden

Country Status (6)

Country Link
EP (1) EP1423119A4 (de)
JP (1) JP2004532854A (de)
BR (1) BR0210060A (de)
CA (1) CA2446795A1 (de)
MX (1) MXPA03010255A (de)
WO (1) WO2002089806A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009506988A (ja) * 2005-08-19 2009-02-19 エラン ファーマシューティカルズ，インコーポレイテッド ガンマセクレターゼの架橋ｎ−環状スルホンアミド阻害剤
EP2690102A1 (de) 2012-07-24 2014-01-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bizyklische Aza-Amide zur Behandlung psychischer Erkrankungen
US9914732B2 (en) * 2014-01-24 2018-03-13 Max-Planck-Gesellschaft Zur Forderung Der Wissensc Haften E.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
EP2899192A1 (de) * 2014-01-24 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane Derivate zur Behandlung von Psychiatrischen Störungen
RU2017106928A (ru) * 2014-08-27 2018-10-01 Ф. Хоффманн-Ля Рош Аг Замещенные производные пиразино[2,1-а]изохинолина для лечения заболеваний цнс
US10597378B2 (en) 2017-09-08 2020-03-24 National Health Research Institutes Tetrahydroisoquinolines for use as MOR/NOP dual agonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042245A1 (en) * 1999-12-08 2001-06-14 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
WO2002032901A2 (en) * 2000-10-19 2002-04-25 Pfizer Products Inc. Bridged piperazine derivatives
WO2002060894A2 (en) * 2001-01-30 2002-08-08 Bristol-Myers Squibb Company Sulfonamide lactam inhibitors of factor xa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880927A (en) * 1972-06-19 1975-04-29 Lilly Co Eli {62 -Phenyl-{62 ,{62 -difluoroethylamines
SI20638A (sl) * 1998-07-17 2002-02-28 Agouron Pharmaceuticals, Inc. Spojine, sestavki in metode za stimulacijo rasti in podaljševanja nevronov

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042245A1 (en) * 1999-12-08 2001-06-14 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
WO2002032901A2 (en) * 2000-10-19 2002-04-25 Pfizer Products Inc. Bridged piperazine derivatives
WO2002060894A2 (en) * 2001-01-30 2002-08-08 Bristol-Myers Squibb Company Sulfonamide lactam inhibitors of factor xa

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GUO, C. ET AL: "A concise synthesis of AG5473/5507 utilizing N-acyliminium ion chemistry", TETRAHEDRON LETTERS, 41(28), 5307-5311 CODEN: TELEAY; ISSN: 0040-4039, 2000, XP004222061 *
See also references of WO02089806A1 *

Also Published As

Publication number Publication date
BR0210060A (pt) 2004-08-17
EP1423119A1 (de) 2004-06-02
CA2446795A1 (en) 2002-11-14
MXPA03010255A (es) 2005-03-07
JP2004532854A (ja) 2004-10-28
WO2002089806A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
GB0126878D0 (en) Aquacare
AU2002360430A8 (en) 14-methyl-epothilones
DE60231872D1 (en) Echinocandinverfahren
DE60216319D1 (en) Heteroaryl-substituierte aminocyclohexan-derivate
EP1423119A4 (de) Heterobicyclen fkbp-liganden
AU2002313943A8 (en) Electromobile
GB0108861D0 (en) Matchit
GB0125662D0 (en) Formultion
AU2001100134A4 (en) Enviro-trap
CA93646S (en) Fauteuil
CA93075S (en) Travelbag
CA92978S (en) Photo-changer
CA92665S (en) Bedboard
CA91502S (en) Bedboard
AU2479P (en) Crackerjack xTriticosecale
CA93125S (en) Tilt-latch
AU2288P (en) Prime322 xTriticosecale
CA93126S (en) Titlt-latch
CA93127S (en) Tilt-latch
AU2002303713A1 (en) Heterobicycles fkbp-ligands
PL112785U1 (en) Spoon-net
AU148518S (en) Ringbinder
GB0223952D0 (en) Boxad
IL144801A0 (en) Bite-valve
GB0124761D0 (en) Hedgiepot

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031210

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050228

17Q First examination report despatched

Effective date: 20070307

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070918